메뉴 건너뛰기




Volumn 101, Issue 10, 2016, Pages e405-e406

Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis

Author keywords

Post essential thrombocytosis myelofibrosis; Post polycythemia vera; Primary myelofibrosis; Prognostic scores

Indexed keywords

CALRETICULIN; HEMOGLOBIN;

EID: 84989322208     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2016.149013     Document Type: Letter
Times cited : (22)

References (12)
  • 1
    • 30844443469 scopus 로고    scopus 로고
    • Pathogenesis of myelofibrosis with myeloid metaplasia
    • Tefferi A. Pathogenesis of myelofibrosis with myeloid metaplasia. J Clin Oncol. 2005;23(33):8520-8530.
    • (2005) J Clin Oncol , vol.23 , Issue.33 , pp. 8520-8530
    • Tefferi, A.1
  • 2
    • 77957955039 scopus 로고    scopus 로고
    • Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis
    • Passamonti F, Cervantes F, Vannucchi AM, et al. Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis. Blood. 2010;116(15):2857-2858.
    • (2010) Blood , vol.116 , Issue.15 , pp. 2857-2858
    • Passamonti, F.1    Cervantes, F.2    Vannucchi, A.M.3
  • 3
    • 43549125836 scopus 로고    scopus 로고
    • A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis
    • Passamonti F, Rumi E, Caramella M, et al. A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis. Blood. 2008;111(7):3383-3387.
    • (2008) Blood , vol.111 , Issue.7 , pp. 3383-3387
    • Passamonti, F.1    Rumi, E.2    Caramella, M.3
  • 4
    • 0029767865 scopus 로고    scopus 로고
    • Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system
    • Dupriez B, Morel P, Demory JL, et al. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood. 1996;88(3):1013-1018.
    • (1996) Blood , vol.88 , Issue.3 , pp. 1013-1018
    • Dupriez, B.1    Morel, P.2    Demory, J.L.3
  • 5
    • 63849328927 scopus 로고    scopus 로고
    • New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
    • Cervantes F, Dupriez B, Pereira A, et al. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood. 2009;113(13):2895-2901.
    • (2009) Blood , vol.113 , Issue.13 , pp. 2895-2901
    • Cervantes, F.1    Dupriez, B.2    Pereira, A.3
  • 6
    • 79952087335 scopus 로고    scopus 로고
    • DIPSS plus: A refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status
    • Gangat N, Caramazza D, Vaidya R, et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol. 2011; 29(4):392-397.
    • (2011) J Clin Oncol , vol.29 , Issue.4 , pp. 392-397
    • Gangat, N.1    Caramazza, D.2    Vaidya, R.3
  • 7
    • 84930368507 scopus 로고    scopus 로고
    • Mutation enhanced international prognostic scoring system (MIPSS) for primary myelofibrosis: An AGIMM and IWG-MRT project
    • Vannucchi AM, Guglielmelli P, Rotunno G, et al. Mutation enhanced international prognostic scoring system (MIPSS) for primary myelofibrosis: an AGIMM and IWG-MRT project. Blood. 2014;124(21):405.
    • (2014) Blood , vol.124 , Issue.21 , pp. 405
    • Vannucchi, A.M.1    Guglielmelli, P.2    Rotunno, G.3
  • 8
    • 84930340282 scopus 로고    scopus 로고
    • El al. Integration of mutations and karyotype towards a genetics-based prognostic scoring system (GPSS) for primary myelofibrosis
    • Tefferi A, Guglielmelli P, Finke C, el al. Integration of mutations and karyotype towards a genetics-based prognostic scoring system (GPSS) for primary myelofibrosis. Blood. 2014;124(21):406.
    • (2014) Blood , vol.124 , Issue.21 , pp. 406
    • Tefferi, A.1    Guglielmelli, P.2    Finke, C.3
  • 9
    • 84958928344 scopus 로고    scopus 로고
    • The evolution and clinical relevance of prognostic classification systems in myelofibrosis
    • Bose P, Verstovsek S. The evolution and clinical relevance of prognostic classification systems in myelofibrosis. Cancer. 2016;122(5):681-692.
    • (2016) Cancer , vol.122 , Issue.5 , pp. 681-692
    • Bose, P.1    Verstovsek, S.2
  • 10
    • 84889078595 scopus 로고    scopus 로고
    • Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage
    • Boiocchi L, Mathew S, Gianelli U, et al. Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage. Mod Pathol. 2013;26(12):1577-1585.
    • (2013) Mod Pathol , vol.26 , Issue.12 , pp. 1577-1585
    • Boiocchi, L.1    Mathew, S.2    Gianelli, U.3
  • 11
    • 84904056081 scopus 로고    scopus 로고
    • CALR and ASXL1 muta-tions-based molecular prognostication in primary myelofibrosis: An international study of 570 patients
    • Tefferi A, Guglielmelli P, Lasho TL, et al. CALR and ASXL1 muta-tions-based molecular prognostication in primary myelofibrosis: an international study of 570 patients. Leukemia. 2014;28(7):1494-1500.
    • (2014) Leukemia , vol.28 , Issue.7 , pp. 1494-1500
    • Tefferi, A.1    Guglielmelli, P.2    Lasho, T.L.3
  • 12
    • 84973882745 scopus 로고    scopus 로고
    • Epidemiology and clinical relevance of mutations in post-polycythemia vera and post-essential thrombocythemia myelofibrosis. A study on 359 patients of the AGIMM group
    • Rotunno G, Pacilli A, Artusi V, et al. Epidemiology and clinical relevance of mutations in post-polycythemia vera and post-essential thrombocythemia myelofibrosis. A study on 359 patients of the AGIMM group. Am J Hematol. 2016;91(7):681-686.
    • (2016) Am J Hematol , vol.91 , Issue.7 , pp. 681-686
    • Rotunno, G.1    Pacilli, A.2    Artusi, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.